Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bausch + Lomb, an eye health company, has named Robert Grant as new CEO and president of its global surgical business, effective August 1, 2010.
Subscribe to our email newsletter
In 2006, Mr Grant began his tenure as Allergan’s corporate vice president and president. Prior to that he has served as acting chairman, president and CEO of Biolase Technology. He joined Biolase in 2003 as COO, and also served the organisation as CFO.
From 1997 to 2003, Mr Grant held management positions with Lumenis (formerly Coherent Medical Group), including executive vice president of its ophthalmic business unit, executive vice president of its surgical business unit, vice president of business development and managing director of European Operations.
Andy Corley, the president of Bausch + Lomb’s surgical business since 2008, will transition into a role as senior advisor to Brent Saunders and the B+L senior leadership team.
Brent Saunders, CEO of Bausch + Lomb, said: “Robert is an exceptional leader and innovator in the medical products industry, with global operating expertise extending across devices and pharmaceuticals. His recruitment is another successful step in the actions we are implementing to transform Bausch + Lomb into a high-performance global competitor.”